ATE256661T1 - Bispiperidine mit antithrombotischer wirkung - Google Patents
Bispiperidine mit antithrombotischer wirkungInfo
- Publication number
- ATE256661T1 ATE256661T1 AT99929495T AT99929495T ATE256661T1 AT E256661 T1 ATE256661 T1 AT E256661T1 AT 99929495 T AT99929495 T AT 99929495T AT 99929495 T AT99929495 T AT 99929495T AT E256661 T1 ATE256661 T1 AT E256661T1
- Authority
- AT
- Austria
- Prior art keywords
- bispiperidine
- antithrombotic effect
- antithrombotic
- therepeutically
- fibrinogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809166A FR2781223B1 (fr) | 1998-07-17 | 1998-07-17 | Bispiperidines et leurs applications therapeutiques |
| PCT/FR1999/001745 WO2000003986A1 (fr) | 1998-07-17 | 1999-07-16 | Bispiperidines comme agents antithrombotiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE256661T1 true ATE256661T1 (de) | 2004-01-15 |
Family
ID=9528732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99929495T ATE256661T1 (de) | 1998-07-17 | 1999-07-16 | Bispiperidine mit antithrombotischer wirkung |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6333338B1 (de) |
| EP (1) | EP1098878B1 (de) |
| JP (1) | JP2002520393A (de) |
| KR (1) | KR100584032B1 (de) |
| CN (1) | CN1286812C (de) |
| AT (1) | ATE256661T1 (de) |
| AU (1) | AU761655B2 (de) |
| BR (1) | BR9912835A (de) |
| CA (1) | CA2337776A1 (de) |
| DE (1) | DE69913701T2 (de) |
| DK (1) | DK1098878T3 (de) |
| EA (1) | EA003674B1 (de) |
| ES (1) | ES2212576T3 (de) |
| FR (1) | FR2781223B1 (de) |
| HU (1) | HUP0103623A3 (de) |
| IL (2) | IL140581A0 (de) |
| NO (1) | NO318963B1 (de) |
| NZ (1) | NZ509170A (de) |
| PL (1) | PL193804B1 (de) |
| PT (1) | PT1098878E (de) |
| SK (1) | SK152001A3 (de) |
| TR (1) | TR200100159T2 (de) |
| UA (1) | UA65631C2 (de) |
| WO (1) | WO2000003986A1 (de) |
| ZA (1) | ZA200100238B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001047874A1 (en) * | 1999-12-24 | 2001-07-05 | Smithkline Beecham P.L.C. | (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| CA2529486A1 (en) * | 2003-06-18 | 2004-12-23 | Nst Neurosurvival Technologies Ltd. | Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| MX2022000133A (es) | 2019-07-01 | 2022-04-27 | Tonix Pharma Ltd | Anticuerpos anti-cd154 y usos de los mismos. |
| CN116963750A (zh) | 2021-01-06 | 2023-10-27 | 通尼克斯制药有限公司 | 用经修饰的抗-cd154抗体诱导免疫耐受的方法 |
| WO2025248134A1 (en) | 2024-05-31 | 2025-12-04 | Tonix Pharma Limited | Treatment methods comprising administration of modified cd154 antibodies |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
-
1998
- 1998-07-17 FR FR9809166A patent/FR2781223B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-16 PL PL99345418A patent/PL193804B1/pl not_active IP Right Cessation
- 1999-07-16 IL IL14058199A patent/IL140581A0/xx active IP Right Grant
- 1999-07-16 EP EP99929495A patent/EP1098878B1/de not_active Expired - Lifetime
- 1999-07-16 AU AU46290/99A patent/AU761655B2/en not_active Ceased
- 1999-07-16 WO PCT/FR1999/001745 patent/WO2000003986A1/fr not_active Ceased
- 1999-07-16 AT AT99929495T patent/ATE256661T1/de not_active IP Right Cessation
- 1999-07-16 CN CNB998097772A patent/CN1286812C/zh not_active Expired - Fee Related
- 1999-07-16 EA EA200100150A patent/EA003674B1/ru not_active IP Right Cessation
- 1999-07-16 DK DK99929495T patent/DK1098878T3/da active
- 1999-07-16 SK SK15-2001A patent/SK152001A3/sk unknown
- 1999-07-16 NZ NZ509170A patent/NZ509170A/en unknown
- 1999-07-16 DE DE69913701T patent/DE69913701T2/de not_active Expired - Fee Related
- 1999-07-16 PT PT99929495T patent/PT1098878E/pt unknown
- 1999-07-16 TR TR2001/00159T patent/TR200100159T2/xx unknown
- 1999-07-16 UA UA2001021081A patent/UA65631C2/uk unknown
- 1999-07-16 KR KR1020017000665A patent/KR100584032B1/ko not_active Expired - Fee Related
- 1999-07-16 BR BR9912835-7A patent/BR9912835A/pt not_active Application Discontinuation
- 1999-07-16 US US09/743,910 patent/US6333338B1/en not_active Expired - Fee Related
- 1999-07-16 ES ES99929495T patent/ES2212576T3/es not_active Expired - Lifetime
- 1999-07-16 JP JP2000560094A patent/JP2002520393A/ja active Pending
- 1999-07-16 CA CA002337776A patent/CA2337776A1/en not_active Abandoned
- 1999-07-16 HU HU0103623A patent/HUP0103623A3/hu unknown
-
2000
- 2000-12-26 IL IL140581A patent/IL140581A/en not_active IP Right Cessation
-
2001
- 2001-01-09 ZA ZA200100238A patent/ZA200100238B/en unknown
- 2001-01-15 NO NO20010252A patent/NO318963B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199900598A1 (ru) | Производные 1-арил- и пиридилпиразола с пестицидными свойствами | |
| NO933999L (no) | Fibrinogenreseptorantagonister | |
| TR199701356A2 (xx) | L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler. | |
| PT892780E (pt) | Analogos de m-amidino fenilo como inibidores do factor xa | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| BR0208365A (pt) | Derivados de 2-amino-propanol | |
| ES2160408T3 (es) | Trifluorfenil-triazolpirimidinas fungicidas. | |
| BR0111981A (pt) | herbicidas de piridina substituìda | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| CR8193A (es) | Piperazina con o sustituida de grupos feniles y su uso como inhibidores de glyt 1 | |
| EA199900936A1 (ru) | Фунгицидные трифторметилалкиламинотриазолопиримидины | |
| DE69328072D1 (de) | Umweltfreundliche Zusammensetzungen zur Verbesserung des Viskositätsindexes | |
| BR0009421A (pt) | Inibidores de ligação lfa-1 aos icams e uso dos mesmos | |
| BG103558A (en) | Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| SE9801494D0 (sv) | Novel use | |
| DE69913701T2 (de) | Bispiperidine mit antithrombotischer wirkung | |
| SE9903290D0 (sv) | Novel compounds | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| TR200402343T4 (tr) | Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit | |
| EA200200798A1 (ru) | Кальцилитические соединения | |
| EA200100152A1 (ru) | Замещенные пиперазиноны и их терапевтическое применение | |
| EA200100299A1 (ru) | Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека | |
| DE58909628D1 (de) | Verwendung von transferrin zur bekämpfung der toxischen wirkung des endotoxins bei der endotoxinämie | |
| DE59908293D1 (de) | Polymermischungen zur Verbesserung der Schmierwirkung von Mitteldestillaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1098878 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |